Last reviewed · How we verify
NCT05035199
Spiritual Resources and Distress in Patients With Affective Disorders
trial testing Spiritual Distress and Resources Questionnaire (SDRQ) in Mood Disorders in 236 participants. Completed in 30 September 2022.
30 September 2022
Quick facts
| Lead sponsor | Psychiatric University Hospital, Zurich |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 236 |
| Start date | 1 July 2021 |
| Primary completion | 30 September 2022 |
| Estimated completion | 30 September 2022 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Spiritual Distress and Resources Questionnaire (SDRQ)
Conditions studied
- Mood Disorders — all drugs for Mood Disorders →
Sponsor
Psychiatric University Hospital, Zurich
Who can join
18 and older, any sex, with Mood Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this study, the investigators want to assess spiritual resources, spiritual distress and spiritual coping in patients with psychiatric disorders of the affective spectrum with a new designed questionnaire the Spiritual Distress and Resources Questionnaire (SDRQ)
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Including the spiritual dimension in the treatment of patients with affective disorders: validation of the spiritual distress and resources questionnaire (SDRQ).
Stutz G, Hotzy F, Eisenhut A, von Keyserlingk F, et al · · 2025 · PMID 39934878 · DOI 10.1186/s40359-025-02438-0
Verify or expand the search:
- PubMed search for NCT05035199
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Mood Disorders
Currently open trials in the same condition.
- NCT07523490 — Investigation on Suicide Risk Factors of Patients With Mood Disorders · recruiting
- NCT07362511 — Imagery Rescripting in Primary Care · NA · recruiting
- NCT07211750 — Integrated Care for Older Adults With Major Depression and Physical Multimorbidity - The I-CONNECT · NA · recruiting
- NCT07088939 — Feasibility and Acceptability of an E-learning Dialectical Behavior Therapy Skills Course · NA · recruiting
- NCT06412315 — 7T Amygdala and Citalopram Study · NA · recruiting
Other Psychiatric University Hospital, Zurich trials
Trials by the same sponsor.
- NCT04100213 — Real-Time Assessment of Stress and Stress Response · NA · withdrawn
- NCT05939765 — Pharmacologic Treatment in Legal Offenders With Schizophrenia, a Prospective Observational Mirror Image Study. · withdrawn
- NCT04096625 — Enhancement of a Psychotherapeutic Intervention Through Transcranial Direct Current Stimulation (tDCS) · NA · unknown
- NCT05902819 — Reconsolidation Blockade of Intrusive Trauma- and Cocaine-related Memories · NA · completed
- NCT05911529 — Motivational Interviewing for Patients With Acute Psychosis · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05035199 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Psychiatric University Hospital, Zurich
- Last refreshed: 7 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05035199.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing